Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]    
Product sales, net $ 11,060,636 $ 11,529,402
Cost of goods sold 4,063,001 4,798,418
Gross Profit 6,997,635 6,730,984
Operating Expenses:    
Selling, general and administrative 13,129,950 17,377,282
Research and development 1,159,009 1,320,003
Total Operating Expenses 14,288,959 18,697,285
Gain on collection of related party notes receivable (Note 3) 379,486 0
Gain on change in derivative liability (Note 8) 147,200 0
Impairment of inventory (Note 4) (3,562,459) 0
Impairment of PhytoSPHERE goodwill and intangible assets (Note 7) (2,746,512) 0
Litigation settlement income (Notes 3 and 9) 0 756,714
Total Operating Expenses (20,071,244) (17,940,571)
Operating Loss (13,073,609) (11,209,587)
Other (expense) income:    
Interest income 27,658 18,287
Interest expense (1,086,793) (968,615)
Other (8,554) (73,213)
Total Other (Expense) Income (1,067,689) (1,023,541)
Loss before provision for income taxes (14,141,298) (12,233,128)
Provision for income taxes 0 0
Net Loss $ (14,141,298) $ (12,233,128)
Weighted average common shares outstanding - Basic & diluted 52,660,749 35,142,094
Net income per common share - Basic & diluted $ (.26) $ (0.35)